Risk perception by healthcare professionals related to drug use during pregnancy: A Swiss survey

Swiss Medical Weekly

Volumn 144, Issue , 2014, Pages

  Csajka, Chantal ^a   Jaquet, Aurélie ^a   Winterfeld, Ursula ^b   Meyer, Yvonne ^c   Einarson, Adrienne ^d   Panchaud, Alice ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c School of Health Sciences Midwifery Section   (Switzerland)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Drugs; Healthcare professionals; Pregnancy; Risk perception

Indexed keywords

PARACETAMOL;

ARTICLE; AWARENESS; BOOK; DRUG USE; E-MAIL; FEMALE; GYNECOLOGIST; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HUMAN; MALE; MEDICAL SOCIETY; MIDWIFE; PEDIATRICIAN; PERCEPTION; PHARMACIST; PREGNANCY; QUESTIONNAIRE; RISK ASSESSMENT; ADULT; ADVERSE DRUG REACTION; AGED; ATTITUDE TO HEALTH; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; GYNECOLOGY; INFORMATION SEEKING; MIDDLE AGED; PEDIATRICS; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SWITZERLAND; VERY ELDERLY; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INFORMATION SEEKING BEHAVIOR; MALE; MATERNAL EXPOSURE; MIDDLE AGED; MIDWIFERY; PEDIATRICS; PERCEPTION; PHARMACISTS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; SWITZERLAND; YOUNG ADULT;

EID: 84899732737     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.13936     Document Type: Article

References (34)

1. Shahin I, Einarson A. Knowledge transfer and translation: examining how teratogen information is disseminated. Birth defects research Part A, Clinical and molecular teratology. 2011;91(11):956-61.
2. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338(16):1128-37. (Pubitemid 28227484)
3. Compendium Suisse des médicaments. In: Documed, ed.
4. Feldman Y, Koren G, Mattice K, Shear H, Pellegrini E, MacLeod SM. Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology. 1989;40(1):37-45. (Pubitemid 19190550)
5. Mitchell AA. Systematic identification of drugs that cause birth defects - a new opportunity. N Engl J Med. 2003;349(26):2556-9. (Pubitemid 38010084)
6. Schaefer C, Spielmann H, Vetter K, Weber-Schöndorfer C. Arzneimittel in Schwangerschaft und Stillzeit. 8 ed: Urban & Fischer Verlag/Elsevier GmbH. 2012.
7. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 9th ed: Lippincott Williams & Wilkins (LWW) 2011.
8. Polifka JE, Faustman EM, Neil N. Weighing the risks and the benefits: a call for the empirical assessment of perceived teratogenic risk. Reprod Toxicol. 1997;11(4):633-40.
9. Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health. 2005;8(4):214-20. (Pubitemid 41618841)
10. Koren G, Bologa M, Long D, Feldman Y, Shear NH. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol. 1989;160(5 Pt 1):1190-4. (Pubitemid 19144484)
11. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207-14.
12. Koren G, Levichek Z. The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S248-52.
13. Pole M, Einarson A, Pairaudeau N, Einarson T, Koren G. Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. J Clin Pharmacol. 2000;40(6):573-7.
14. Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. The primary care companion to CNS disorders. 2011;13(2).
15. Bentur Y, Horlatsch N, Koren G. Exposure to ionizing radiation during pregnancy: perception of teratogenic risk and outcome. Teratology. 1991;43(2):109-12.
16. Jasper JD, Goel R, Einarson A, Gallo M, Koren G. Effects of framing on teratogenic risk perception in pregnant women. Lancet. 2001;358(9289):1237-8.
17. Koren G, Pastuszak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 1990;41(6):657-61. (Pubitemid 20191977)
18. Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G. The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod Toxicol. 1999;13(4):313-9.
19. Walfisch A, Sermer C, Matok I, Einarson A, Koren G. Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression. Can J Psychiatry. 2011;56(12):761-7.
20. Widnes SF, Schjott J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug safety: an international journal of medical toxicology and drug experience. 2013;36(6):481-9.
21. Goodwin J, Rieder S, Rieder MJ, Matsui D. Counseling regarding pregnancy - related drug exposures by family physicians in Ontario. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique. 2007;14(1):e58-69.
22. Ratnapalan S, Bona N, Chandra K, Koren G. Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol. 2004;182(5):1107-9. (Pubitemid 38525497)
23. Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J obstet Gynecol Reprod Biol. 2001;95(1):127-31. (Pubitemid 32208683)
24. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA: the journal of the American Medical Association. 1997;277(6):488-94.
25. Centre de référence sur les agents tératogè nes de Paris. Available from: www.lecrat.org
26. Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Berlin. Available from: www.embryotox.de
27. L'emploi dans le domaine de la santé. In: statistique Ofdl, ed. 2007.
28. Richoz C, Ayer A, Berchtold A, Richoz S. Record keeping by Swiss physiotherapists - a national survey of knowledge regarding legal requirements. Swiss Med Wkly. 2011;141:w13291.
29. Allegra CJ, Hall R, Yothers G. Prevalence of burnout in the u.s. Oncology community: results of a 2003 survey. Journal of oncology practice / American Society of Clinical Oncology. 2005;1(4):140-7.
30. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, et al. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol. 2007;14(11):3043-53. (Pubitemid 47594298)
31. Fletcher RH, Fletcher SW. Clinical epidemiology. the essentials. 4th ed 2005.
32. Delaloye JF, Rousso P, Buclin T, De Grandi P, Vial Y, Hohlfeld P. Médicaments grossesse et lactation: Medecine & Hygiene. 2006.
33. Ferreira E. Grossesse et allaitement: guide thérapeutique.: CHU Sainte-Justine 2007.
34. Reprotox. Reprod Toxicol. 2013.